TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
4.580
+0.130 (2.94%)
Dec 26, 2024, 2:57 PM EST - Market open
TuHURA Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -18.37 | -29.32 | -9.37 |
| Depreciation & Amortization | 0.14 | 0.18 | 0.37 |
| Other Amortization | 1.11 | 0.01 | - |
| Asset Writedown & Restructuring Costs | 0.02 | 16.22 | - |
| Stock-Based Compensation | 0.97 | 0.48 | 0.22 |
| Other Operating Activities | 0.31 | - | -0.29 |
| Change in Accounts Payable | 0.7 | 0.34 | 1.85 |
| Change in Other Net Operating Assets | -0.04 | 0.15 | -0.29 |
| Operating Cash Flow | -15.16 | -11.95 | -7.51 |
| Capital Expenditures | -0.08 | -1.3 | -0.04 |
| Investing Cash Flow | -5.27 | -1.3 | -0.04 |
| Long-Term Debt Issued | - | 2.69 | - |
| Long-Term Debt Repaid | - | - | -0.35 |
| Net Debt Issued (Repaid) | 31.25 | 2.69 | -0.35 |
| Repurchase of Common Stock | - | -0.02 | - |
| Financing Cash Flow | 35.97 | 2.66 | 16.25 |
| Net Cash Flow | 15.55 | -10.59 | 8.71 |
| Free Cash Flow | -15.24 | -13.25 | -7.54 |
| Free Cash Flow Per Share | -0.20 | -0.19 | - |
| Levered Free Cash Flow | - | -8.29 | - |
| Unlevered Free Cash Flow | - | -8.29 | - |
| Change in Net Working Capital | - | -0.82 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.